Last reviewed · How we verify
2028 Pharmaceutical Patent Cliff
72 drugs
154 patents
13 therapeutic areas
Forward-looking
Sponsors most affected (10)
- Pfizer · 9 drugs
- Unknown · 7 drugs
- Pfizer Inc. · 4 drugs
- Baxter · 3 drugs
- Novartis · 3 drugs
- Boehringer Ingelheim · 2 drugs
- Merck & Co. · 2 drugs
- Kyowa Kirin Co., Ltd. · 1 drug
- Generic (originally Schering) · 1 drug
- AstraZeneca · 1 drug
By therapeutic area
Oncology (19)
- — Mitozytrex · Kyowa Kirin Co., Ltd. · Alkylating Drug [EPC] ·
Compound - — Deltasone · Generic (originally Schering) · Corticosteroid [EPC] ·
Formulation - — Derma-Smoothe/Fs · Eurofarma · Corticosteroid [EPC] ·
Formulation - — Lupron · Accord Healthcare S.L.U. · Gonadotropin Releasing Hormone Receptor Agonist
- — Leuprolide Acetate · Pfizer · leuprorelin
- — Arthrotec · Pfizer · diclofenac
- — Spy Agent Green Kit · Renew Pharms · Diagnostic Dye ·
Method of Use - — Rowasa · Meda Pharms · Aminosalicylate [EPC]
- — Kisqali · Novartis · Kinase Inhibitor
- — Afinitor · Novartis · Kinase Inhibitor [EPC] ·
Method of Use - — Estrace · Pfizer · Estrogen ·
Method of Use - — Estring · Pfizer Inc. · Combined Oral Contraceptive (COC) ·
Compound - — Pluvicto · Aaa Usa Novartis · Radioligand Therapeutic Agent [EPC]
- — Camptosar · Pfizer · Topoisomerase Inhibitor
- — Camptosar · Pfizer · Topoisomerase Inhibitor ·
Compound - — Topicort · Taro · Corticosteroid [EPC] ·
Formulation - — Viekira Pak (Copackaged) · AbbVie · Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor
- — Inqovi · Otsuka · Nucleoside Metabolic Inhibitor [EPC]
- — TELOTRISTAT ETIPRATE · Serotonin Synthesis Inhibitor ·
Method of Use
Metabolic (14)
- — Byetta · AstraZeneca · GLP-1 Receptor Agonist [EPC]
- — Omnaris · Takeda Gmbh · ciclesonide
- — Cystagon · Mylan · Cystine Depleting Agent
- — Zosyn · Merck Sharp & Dohme B.V. · beta Lactamase Inhibitor
- — Zuragard · isopropanol
- — Differin · Galderma Labs Lp · Retinoid [EPC] ·
Formulation - — Femring · Apil · Estrogen ·
Formulation - — Tradjenta · Boehringer Ingelheim · Dipeptidyl Peptidase 4 Inhibitor [EPC]
- — Vantobra · Pfizer · tobramycin
- — Beconase Aq · Corticosteroid
- — Keppra · Generic (originally UCB Pharma) · Antiepileptic agent ·
Formulation - — Cuvposa · Shionogi · Anticholinergic
- — Glycopyrrolate · Yonsei University ·
Formulation - — Tygacil · Pfizer · Tetracycline
Neuroscience (10)
- — Versed · Generic (originally Roche) · Benzodiazepine (short-acting) ·
Formulation - — Versed · Takeda Pharmaceutical Company Limited · Benzodiazepine ·
Formulation - — Risperdal · Johnson & Johnson (Janssen) · Atypical Antipsychotic [EPC] ·
Method of Use - — Bupivacaine Hydrochloride And Epinephrine · Pfizer Inc. · alpha-Adrenergic Agonist [EPC] ·
Formulation - — Topamax · Janssen ·
Formulation - — Clozaril · Jazz Pharmaceuticals · Atypical Antipsychotic [EPC] ·
Formulation - — Duramorph Pf · Pfizer · Opioid Agonist ·
Formulation - — Renacidin · Baxter · Anti-coagulant
- — Tegretol · Novartis AG (originally Geigy) · Mood Stabilizer [EPC] ·
Method of Use - — Abilify · Generic (originally Otsuka/BMS) · Third-generation antipsychotic (D2 partial agonist) ·
Formulation
Immunology (8)
- — Metro I.V. In Plastic Container · Baxter · Nitroimidazole Antimicrobial [EPC] ·
Formulation - — Dovonex · Vitamin D Analog [EPC] ·
Formulation - — Prograf · Astellas Pharma · Calcineurin Inhibitor Immunosuppressant ·
Method of Use - — MESALAMINE · Aminosalicylate [EPC] ·
Formulation - — Vizamyl · GE HealthCare · Radioactive Diagnostic Agent [EPC]
- — Temovate · Fougera Pharms · Corticosteroid ·
Formulation - — Pulmicort Respules · AstraZeneca K.K. · Corticosteroid [EPC] ·
Method of Use - — Acetaminophen · Polymedica · acetaminophen
Cardiovascular (6)
- — Pradaxa · Boehringer Ingelheim · Direct thrombin inhibitor
- — Epipen · Pfizer Inc. · alpha-Adrenergic Agonist [EPC] ·
Formulation - — Proventil · Merck & Co. · beta2-Adrenergic Agonist
- — Edarbi · Arbor Pharms Ireland · Angiotensin 2 Receptor Blocker
- — Combipres · University Hospital Birmingham · Thiazide-like Diuretic
- — Osmoprep · Salix Pharms · Calculi Dissolution Agent [EPC]
Infectious Disease (4)
- — Zerbaxa · Cubist Pharms · Cephalosporin Antibacterial
- — Tobi · Novartis ·
Formulation - — Tygacil · Fresenius Kabi · Tetracycline-class Antibacterial [EPC]
- — Suprax · cefixime ·
Formulation
Pain (3)
- — Naloxone Hydrochloride · Pfizer Inc. · Mixed opioid agonist-antagonist with opioid antagonist ·
Formulation - — MS Contin · Generic (multiple manufacturers) · Opioid analgesic ·
Formulation - — OxyContin · Purdue Pharma ·
Formulation
Other (2)
- — Natazia · Mochida Pharmaceutical Co., Ltd. · Progestin
- — Acid Reflux Relief · Pfizer · Non-Standardized Plant Allergenic Extract [EPC]
Respiratory (2)
- — Breo Ellipta · Glaxo Grp Ltd · beta2-Adrenergic Agonist
- — Fluticasone Furoate/Umeclidinium/Vilanterol (FUV) · Thammasat University · Combination inhaler (ICS/LAMA/LABA) ·
Formulation
Nephrology (1)
- — Rayaldee · calcifediol ·
Method of Use
Bone (1)
- — Ortho-Novum 10/11-21 · Merck & Co. · Estrogen
Gastroenterology (1)
- — Prepopik · Baxter · magnesium oxide
Hematology (1)
- — Ferrlecit · Vifor Fresenius · Phosphate Binder [EPC]
Subscribe to patent-cliff alerts
Push every new patent expiry into your RSS reader:
Related
- Biosimilar tracker — who's competing for each post-cliff originator
- Patent cliff revenue calculator
- 2028 patent expiries dataset (CSV / JSON)